3544-24-9
3544-24-9 结构式
基本信息
间氨基苯甲酰胺
3-氯基苯甲酰胺
3-氨基苯丙酰胺98%
3-氨基苯甲酰胺,98%
3-AMINOBENZAMIDE
M-AMINOBENZAMIDE
3-amino-benzamid
Benzamide, 3-amino-
Benzamide, m-amino-
m-amino-benzamid
3-AB
m-Amino Benzamide 3-Amino Benzamide
Benzamide, 3-amino- (9CI)
3-Aminobenzamide,98%
META-AMINOBENZAMIDE
3-AB, 3-ABA
物理化学性质
安全数据
3544-24-9(安全特性,毒性,储运)
知名试剂公司产品信息
3-Aminobenzamide, 98%(3544-24-9)
3-Aminobenzamide,>98.0%(T)(3544-24-9)
| 报价日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
| 2024/01/25 | HY-15045 | 3-氨基苯甲酰胺 INO-1001 | 3544-24-9 | 5mg | 970元 |
| 2024/01/25 | HY-15045 | 3-氨基苯甲酰胺 INO-1001 | 3544-24-9 | 10mM * 1mLin DMSO | 1070元 |
| 2024/01/25 | HY-15045 | 3-氨基苯甲酰胺 INO-1001 | 3544-24-9 | 10mg | 1700元 |
常见问题列表
| Target | Value |
|
PARP
() |
3-Aminobenzamide (PARP-IN-1) (>1 μM) causes more than 95% inhibition of PARP activity without significant cellular toxicity. INO-1001 significantly sensitizes CHO cells by blocking most of the DNA repair occurring between radiation fractions. 3-Aminobenzamide significantly improves endothelial function by enhancing the acetylcholine-induced, endothelium-dependent, nitric oxide mediated vasorelaxation after exposure with 400 μM H 2 O 2 .
In a db/db (Lepr db/db ) mouse model, 3-Aminobenzamide ameliorates diabetes-induced albumin excretion and mesangial expansion, and also decreases diabetes-induced podocyte depletion. 3-Aminobenzamide (1.6 mg/kg via intracerebral injection) prevents NAD + depletion and improves water maze performance after controlled cortical impact (CCI) in mice.